2025-12-06 - Analysis Report
Okay, here's a breakdown of the Chevron (CVX) stock analysis based on the provided data, covering the requested points.

**1) Return Rate vs. S&P 500 (VOO)**

*   **Company Overview:** Chevron Corp is a global energy company involved in the exploration, production, and transportation of oil and natural gas.
*   **CVX Cumulative Return:** 36.14%
*   **VOO Cumulative Return:** 100.58%
*   **Divergence:** Current: -65.9, Relative Divergence: 0.3

**Analysis:**

*   Chevron has significantly underperformed the S&P 500 (VOO) over the period considered.  The cumulative return divergence is a substantial -65.9%.
*   The relative divergence of 0.3 suggests that the current divergence is very close to the most negative divergence observed in the provided data range. It is practically at the bottom of the range.

**Alpha, Beta Analysis:**

| Year      | CAGR    | MDD     | Alpha   | Beta    | Cap(B)  |
|-----------|---------|---------|---------|---------|---------|
| 2015-2017 | 33.0%   | 65.9%   | 5.0%    | 0.1     | 250.0   |
| 2016-2018 | 21.0%   | 71.9%   | 6.0%    | 0.2     | 217.2   |
| 2017-2019 | 3.0%    | 71.9%   | -19.0%   | 0.9     | 240.6   |
| 2018-2020 | -10.0%  | 79.6%   | -33.0%   | 0.7     | 168.6   |
| 2019-2021 | 22.0%   | 79.6%   | -25.0%   | 0.6     | 234.3   |
| 2020-2022 | 85.0%   | 83.2%   | 86.0%   | 0.3     | 358.4   |
| 2021-2023 | 49.0%   | 83.2%   | 47.0%   | 0.4     | 297.8   |
| 2022-2024 | -6.0%  | 83.2%   | -26.0%   | 0.2     | 289.2   |
| 2023-2025 | -46.0% | 74.8%   | -111.0% | 0.6     | 302.7   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate (CAGR) shows variable performance over different periods, with significant growth in 2020-2022 but recent negative growth.
*   **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating significant potential for losses.
*   **Alpha:** Alpha, representing performance above the benchmark, is highly volatile, with significantly negative values in recent periods.  This confirms the underperformance compared to the market.  The -111% in 2023-2025 is alarming.
*   **Beta:** Beta fluctuates, suggesting varying degrees of correlation with the market. Lower beta values means less correlation to the market, higher beta means the opposite.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 151.59
*   **Last Market Data:** Price: 150.19, Previous Close: 152.26, Change: -1.36
*   **5-day SMA:** 150.91
*   **20-day SMA:** 152.61
*   **60-day SMA:** 154.45

**Analysis:**

*   The current price is below both the 5-day and 20-day SMAs, suggesting a short-term downward trend. The fact that the 5-day SMA is below the 20-day SMA also supports this.
*   The 20-day SMA is below the 60-day SMA, indicating a medium-term downward trend as well.

**3) RSI, PPO, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 45.73
*   **PPO:** -0.0429
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (12 shares - Safe - MRI:0.80) Dividend_1.71 (Cash Ratio: 0% on 2025-11-18)
*   **Recent Divergence Change (20 days):** -6.1 (downward trend)
*   **Expected Return:** 994.9%

**Analysis:**

*   **MRI:**  A medium investment rating suggests moderate risk, which seems optimistic given the other indicators.
*   **RSI:** The RSI of 45.73 is neutral, neither overbought nor oversold.
*   **PPO:** The negative PPO (-0.0429) suggests a bearish trend, as the short-term moving average is below the long-term moving average.
*   **Hybrid Signal:** The signal recommends buying 90% of available cash, indicating a relatively bullish stance despite recent negative price action.
*   **Divergence Change:**  The negative divergence change reinforces the short-term downward trend.
*   **Expected Return:** The incredibly high expected return (994.9%) is highly suspect and should be treated with extreme caution. This likely reflects a model outlier or error, or a misunderstanding of the parameters/scope of the return.

**4) Recent News & Significant Events**

*   **[2025-12-02] Evaluating Chevron (CVX) Stock's Actual Performance:**  This suggests a focus on whether the stock's performance is meeting expectations.
*   **[2025-12-05] Has The Market Mispriced Chevron After A Flat 2024 Share Performance?:** This highlights the question of whether the market has correctly valued the company after a period of stagnation.
*   **[2025-12-05] Chevron Corporation $CVX Shares Sold by Epoch Investment Partners Inc.:** This is a bearish signal, indicating institutional selling pressure.
*   **[2025-12-05] Chevron Approves $2B Gorgon Stage 3 To Boost Australian Gas Supply:** This is a positive development, showing investment in future production.
*   **[2025-12-05] Analysts’ Opinions Are Mixed on These Energy Stocks: Ovintiv (OVV), Enbridge (ENB) and Chevron (CVX):** This indicates uncertainty about the future performance of the company.
*   **[2025-12-04] Can CVX stock resist broad market declines - Rate Hike & Verified Chart Pattern Signals:**  This article discusses Chevron's ability to withstand broad market downturns, noting potential resistance signals

**Analysis of News:** The news is a mixed bag. The Gorgon project is positive, but the institutional selling and mixed analyst opinions, combined with the focus on "mispricing" and resistance to market declines, suggest significant concerns about Chevron's current valuation and future prospects.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.08)
*   **Target Price:** Avg: 172.67 / High: 204.00 / Low: 124.00

**Analysis:**

*   Despite the recent negative performance, analysts, on average, maintain a "Buy" rating.
*   The target price range is wide, indicating uncertainty.  The low target is significantly below the average and suggests some analysts are quite bearish.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-11-06 | 1.83 | 48.17 B$    |
| 2025-08-07 | 1.45 | 44.38 B$    |
| 2025-05-08 | 2.01 | 46.10 B$    |
| 2024-11-07 | 2.49 | 48.93 B$    |
| 2025-11-06 | 2.49 | 48.93 B$ |

**Analysis:**

*  The most recent EPS is $1.83, showing a decline compared to the previous period (2024-11-07, $2.49).
* Revenue has also decreased from $48.93B (2024-11-07) to $48.17B.
* This suggests a weakening financial performance in the most recent quarter compared to the previous year.
* The repeat data for 2025-11-06 (2.49, 48.93) is odd, and should be investigated for possible data entry errors.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $48.17B   | 31.12%        |
| 2025-06-30   | $44.38B   | 29.69%        |
| 2025-03-31   | $46.10B   | 29.00%        |
| 2024-12-31   | $48.33B   | 27.34%        |
| 2024-09-30   | $48.93B   | 29.15%        |

Capital and Profitability:

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $189.84B  | 1.86%  |
| 2025-06-30   | $146.42B  | 1.70%  |
| 2025-03-31   | $149.24B  | 2.35%  |
| 2024-12-31   | $152.32B  | 2.13%  |
| 2024-09-30   | $156.20B  | 2.87%  |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable but shows a slight decline in the most recent quarter.
*   **Profit Margin:** Profit margins are healthy, but they have fluctuated and are generally increasing.
*   **Equity:** Equity increased significantly in the most recent quarter (2025-09-30).
*   **ROE:** Return on Equity (ROE) has decreased significantly, despite the increased equity, suggesting less efficient capital utilization. The ROE is lower than the past four quarters..

**7) Comprehensive Analysis**

Chevron is showing concerning signs. While analysts maintain a "Buy" consensus, the stock has significantly underperformed the S&P 500. The negative alpha and recent decline in price, revenue, and ROE are worrying. While the company is investing in future projects (Gorgon), institutional selling and mixed analyst opinions suggest caution.

The high expected return (994.9%) is likely an anomaly and should be disregarded.

**Overall Recommendation:**

Based on the data, a **cautious stance is warranted.**  While the analyst consensus is "Buy," the negative trends and underperformance suggest that the stock may not be a strong investment at this time. Further investigation into the reasons for the declining revenue and ROE, as well as the factors contributing to the underperformance compared to the S&P 500, is necessary. Monitor the stock's performance closely and consider alternative investments with stronger growth potential. The recommendation to buy 90% of cash is questionable given these negative signals, unless one has additional proprietary information.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.